Mediantechn (ALMDT.PA) stock: key figures, P/E, revenue and dividend
Health Care · Health Care Technology · France · ISIN FR0011049824
Mediantechn financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 22.95 m EUR | 23.36 m EUR |
| Gross profit | -21.07 m EUR | 24.05 m EUR |
| Operating income | -22.53 m EUR | -15.94 m EUR |
| EBIT | -21.30 m EUR | -28.27 m EUR |
| Net income | -25.24 m EUR | -34.07 m EUR |
| Diluted EPS – continuing operations | -1.36 EUR | -0.93 EUR |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Mediantechn
Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iCRO, an imaging service for oncology clinical trials; and eyonis, an end-to-end CADe/CADx software as medical devices. The company was founded in 2002 and is based in Valbonne, France.
More stocks
- Kepler Weber S.A (KEPL3.SA)
- DingZing Advanced Materials Inc. (6585.TW)
- Tanvex BioPharma Inc (6541.TW)
- Xi S And D Inc (317400.KS)
- Central Omega Resources Tbk PT (DKFT.JK)
- Solid FAB (SFAB.ST)
- Hsin Yung Chien Co Ltd (2114.TW)
- NG Energy International Corp. (GASX.TO)
- FIRST CAPITAL INC (FCAP)
- Centrotherm International (CTNK.F)
- Xinjiang Zhundong Petroleum (002207.SZ)
- Air Busan Co Ltd (298690.KS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.